Pharma stocks buck market weakness as Dr Reddy’s gains

April 24, 2026

Pharma stocks showed strength on Thursday, defying market weakness. Dr Reddy’s Laboratories saw significant gains, fueled by anticipation of approval for its Semaglutide diabetes drug in Canada. Other pharma companies also experienced upward movement. This defensive sector appeal is attracting investors amid uncertain market conditions and geopolitical concerns.

More To Explore

Midcap bets! InCred picks 6 stocks with up to 54% upside potential. See full list

InCred Equities has identified six midcap stocks across sectors with upside potential of up to 54%, citing attractive valuations and selective opportunities despite volatile markets,

July 11, 2026

Unique Picks: 7 stocks held by a single MF scheme in June; rally up to 120% in 3 months

ETMarkets identified 40 stocks held exclusively by single mutual fund schemes, with select names delivering up to 117% three-month returns while others declined sharply.

July 11, 2026

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003